Imaging Sigma Receptors: Applications in Drug Development
Data up to Jan 2025
Total Citations Per Year
Abstract
References (275)
The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.
1976 • 2,883 citations
Purification, molecular cloning, and expression of the mammalian sigma1-binding site.
1996 • 880 citations
Pitfalls in Oncologic Diagnosis with FDG PET Imaging: Physiologic and Benign Variants
1999 • 827 citations
Neurosteroids: of the nervous system, by the nervous system, for the nervous system.
1997 • 643 citations
NEUROSTEROIDS: A NOVEL FUNCTION OF THE BRAIN
1998 • 598 citations
Cocaine self-administration in dopamine-transporter knockout mice
1998 • 523 citations
Cocaine reward models: Conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice
1998 • 502 citations
Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
1995 • 477 citations
Anatomy of SUV
2000 • 453 citations
Triggering of Myocardial Infarction by Cocaine
1999 • 436 citations
Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus.
1995 • 426 citations
Cloning and Functional Expression of the Human Type 1 Sigma Receptor (hSigmaR1)
1996 • 409 citations
Clinical Role of FDG PET in Evaluation of Cancer Patients
2003 • 388 citations
Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1- propyl)piperidine
1986 • 385 citations
FDG Accumulation and Tumor Biology
1998 • 365 citations
Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
2001 • 356 citations
Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
1986 • 339 citations
Value of [ 11 C]choline-Positron Emission Tomography for Re-Staging Prostate Cancer: A Comparison With [ 18 F]fluorodeoxyglucose-Positron Emission Tomography
2003 • 310 citations
Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors
1996 • 296 citations
??-1 Receptor Ligands
2004 • 286 citations
The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.
2003 • 285 citations
Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis.
2002 • 282 citations
Sigma1 (σ1) receptor agonists and neurosteroids attenuate β25–35-amyloid peptide-induced amnesia in mice through a common mechanism
1998 • 280 citations
Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression
2005 • 252 citations
From tumor biology to clinical PET: A review of positron emission tomography (PET) in oncology
2001 • 252 citations
Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients.
2003 • 248 citations
Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results
1998 • 242 citations
Steroids, neuroactive steroids and neurosteroids in psychopathology
2004 • 239 citations
Sigma receptors: recent advances and new clinical potentials
2000 • 239 citations
Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines.
2002 • 238 citations
Sigma receptors: biology and therapeutic potential
2004 • 235 citations
Effective Tumor Cell Death by σ-2 Receptor Ligand Siramesine Involves Lysosomal Leakage and Oxidative Stress
2005 • 228 citations
Sigma-2 receptors as a biomarker of proliferation in solid tumours
2000 • 226 citations
The interaction between neuroactive steroids and the σ1 receptor function: behavioral consequences and therapeutic opportunities
2001 • 221 citations
Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging.
2002 • 212 citations
Cocaine binding at σ receptors
1988 • 208 citations
Dehydroepiandrosterone Augmentation in the Management of Negative, Depressive, and Anxiety Symptoms in Schizophrenia
2003 • 204 citations
Pharmacotherapies for Treatment of Cocaine Abuse: Preclinical Aspects
1999 • 204 citations
Neurosteroids in depression: a review
2003 • 201 citations
Binding properties of SA4503, a novel and selective σ1 receptor agonist
1996 • 186 citations
Understanding the Molecular Mechanism of Sigma-1 Receptors: Towards A Hypothesis that Sigma-1 Receptors are Intracellular Amplifiers for Signal Transduction
2003 • 182 citations
Neuroactive Neurosteroids as Endogenous Effectors for the Sigma1 (.SIGMA.1) Receptor. Pharmacological Evidence and Therapeutic Opportunities.
1999 • 181 citations
The antidepressant-like effect induced by sigma(1)-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test.
2001 • 178 citations
Cocaine Increases the Endothelial Release of Immunoreactive Endothelin and Its Concentrations in Human Plasma and Urine
1998 • 174 citations
A Genome-Based Resource for Molecular Cardiovascular Medicine
1997 • 171 citations
Positron-emission tomography with [18F]fluorodeoxyglucose
2000 • 170 citations
Visualization of Prostate Cancer with 11C-Choline Positron Emission Tomography
2002 • 167 citations
18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma.
2003 • 165 citations
Exon‐Intron Structure, Analysis of Promoter Region, and Chromosomal Localization of the Human Type 1 σ Receptor Gene
1998 • 161 citations
Quantitative assessment of tumor metabolism using FDG-PET imaging
2000 • 159 citations
σ Receptors: potential medications development target for anti-cocaine agents
2003 • 159 citations
Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
2002 • 159 citations
σ-Receptors in Endocrine Organs: Identification, Characterization, and Autoradiographic Localization in Rat Pituitary, Adrenal, Testis, and Ovary
1989 • 158 citations
The Increased Accumulation of [18F]Fluorodeoxyglucose in Untreated Prostate Cancer
1999 • 154 citations
Neurosteroids Affect Spatial/Reference, Working, and Long-Term Memory of Female Rats
1995 • 154 citations
Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brain
1986 • 152 citations
Sigma1 (σ1) receptor antagonists represent a new strategy against cocaine addiction and toxicity
2002 • 152 citations
Increased Diurnal Plasma Concentrations of Dehydroepiandrosterone in Depressed Patients
1998 • 146 citations
Overexpression of sigma receptors in nonneural human tumors.
1991 • 138 citations
The Role of Sigma Receptors in Depression
2005 • 137 citations
[3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: Autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes
1997 • 135 citations
Pharmacophore Identification for Sigma-1 (σ1) Receptor Binding: Application of the "Deconstruction - Reconstruction - Elaboration" Approach
2005 • 133 citations
Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.
1996 • 133 citations
Clinical profile of remoxipride ‐ a combined analysis of a comparative double‐blind multicentre trial programme
1990 • 132 citations
Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, l -methionine, 67 Ga-citrate, and 125 I-HSA
1999 • 129 citations
Modulation of nmda and dopaminergic neurotransmissions by sigma ligands: Possible implications for the treatment of psychiatric disorders
1996 • 129 citations
Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via σ1-receptors
1997 • 125 citations
Accumulation of [ 11 C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer
2002 • 125 citations
Phencyclidine and σ opiate receptors in brain: Biochemical and autoradiographical differentiation
1985 • 124 citations
σ1 Receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test
1996 • 119 citations
NE-100, a novel sigma receptor ligand: In vivo tests
1993 • 116 citations
Discovery of High-Affinity Ligands of σ1 Receptor, ERG2, and Emopamil Binding Protein by Pharmacophore Modeling and Virtual Screening
2005 • 116 citations
Regulation of [3H]dopamine release from rat striatal slices by sigma receptor ligands.
1994 • 116 citations
Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors.
1996 • 114 citations
ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients.
1998 • 111 citations
The modulation by neurosteroids of the scopolamine-induced learning impairment in mice involves an interaction with sigma1 (σ1) receptors
1998 • 108 citations
Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer
2000 • 108 citations
Fluorine-18-Labelled Fluoropyridines: Advances in Radiopharmaceutical Design
2005 • 106 citations
Sigma receptor ligands modulate contractility, Ca++ influx and beating rate in cultured cardiac myocytes.
1994 • 106 citations
Electrophysiological effects of selective ?-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons
1989 • 106 citations
In vivo evaluation of [11C]SA4503 as a PET ligand for mapping CNS sigma1 receptors
2000 • 104 citations
Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides
2002 • 101 citations
Role of 2-[18F]-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) in the Early Assessment of Response to Chemotherapy in Metastatic Breast Cancer Patients
2000 • 100 citations
Neurosteroids: Molecular mechanisms of action and psychopharmacological significance
1996 • 99 citations
Sigma binding states in the brain; An emerging concept for multiple sites and their relevance for psychiatric disorders
1990 • 99 citations
Modulation by neurosteroids of the in vivo (+)-[3H]SKF-10,047 binding to ?1 receptors in the mouse forebrain
1996 • 97 citations
Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands.
1989 • 97 citations
Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
1999 • 96 citations
Neuropsychopharmacological properties of neuroactive steroids
1999 • 95 citations
Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites.
1993 • 93 citations
18F-labeled radiopharmaceuticals for PET in oncology, excluding FDG
2000 • 91 citations
Differential regulation of σ and PCP receptors after chronic administration of haloperidol and phencyclidine in mice
1989 • 91 citations
Analysis of blood clearance and labeled metabolites for the estrogen receptor tracer [F-18]-16α-Fluorestradiol (FES)
1997 • 91 citations
SA4503, a novel cognitive enhancer with σ1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice
1997 • 89 citations
Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors
1990 • 88 citations
σ Binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture
1995 • 88 citations
Endogenous concentrations of DHEA and DHEA-S Decrease with remission of depression in older adults
2001 • 85 citations
σ Receptor Activation Blocks Potassium Channels and Depresses Neuroexcitability in Rat Intracardiac Neurons
2005 • 83 citations
Current status of PET in breast cancer imaging, staging, and therapy
2001 • 82 citations
Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes
2004 • 82 citations
Comparison of FDG-PET with MIBI-SPECT in the Detection of Breast Cancer and Axillary Lymph Node Metastasis
2000 • 82 citations
σ Receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture
1993 • 82 citations
Measurement of glucose consumption using [18F]fluorodeoxyglucose
2002 • 81 citations
Elevated Blood Levels of Dehydroepiandrosterone Sulphate Vary with Symptom Load in Posttraumatic Stress Disorder: Findings from a Longitudinal Study of Refugees in Sweden
2002 • 81 citations
Inotropic action of σ receptor ligands in isolated cardiac myocytes from adult rats
1995 • 79 citations
Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer.
2001 • 78 citations
Selective σ receptor agonist and antagonist affect dopamine neuronal activity
1989 • 78 citations
Cocaine and σ-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model
2005 • 77 citations
Beneficial Effects of Acute and Repeated Administrations of σ Receptor Agonists on Behavioral Despair in Mice Exposed to Tail Suspension
1998 • 76 citations
Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study
1992 • 76 citations
Motor effects of two sigma ligands mediated by nigrostriatal dopamine neurons
1989 • 75 citations
Evaluation of preoperative ProstaScint™ scans in the prediction of nodal disease
2002 • 74 citations
Ameliorating effect of SA4503, a novel σ1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats
1996 • 74 citations
The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer.
1997 • 74 citations
A Perspective on the New Mechanism of Antidepressants: Neuritogenesis Through Sigma-1 Receptors
2004 • 72 citations
Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain.
1984 • 71 citations
Standardized uptake value and quantification of metabolism for breast cancer imaging with FDG and L-[1-11C]tyrosine PET.
1997 • 71 citations
Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency
1992 • 70 citations
Radioiodinated N-(2-Diethylaminoethyl)benzamide Derivatives with High Melanoma Uptake: Structure−Affinity Relationships, Metabolic Fate, and Intracellular Localization
2000 • 70 citations
PET imaging of prostate cancer with 11C-acetate.
2003 • 70 citations
SA4503, a novel cognitive enhancer, with σ1 receptor agonistic properties
1997 • 68 citations
Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients
2000 • 68 citations
Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent
2001 • 68 citations
Sigma receptors are highly concentrated in the rat pineal gland
1990 • 67 citations
N-alkyl substituted analogs of the σ receptor ligand BD1008 and traditional σ receptor ligands affect cocaine-induced convulsions and lethality in mice
2001 • 66 citations
Highly selective σ receptor ligands elevate inositol 1,4,5-trisphosphate production in rat cardiac myocytes
1998 • 66 citations
Metabotropic neurosteroid/sigma-receptor involved in stimulation of nociceptor endings of mice.
2001 • 65 citations
Sigma receptors are associated with cortical limbic areas in the primate brain
1992 • 65 citations
BMY 14802, a Sigma Receptor Ligand for the Treatment of Schizophrenia
1994 • 63 citations
Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies.
1988 • 62 citations
Clinical Trials with Sigma Ligands
2004 • 61 citations
Positron-emission tomographic imaging of cancer: Glucose metabolism and beyond*
2001 • 61 citations
PET imaging in breast cancer.
2001 • 59 citations
Sigma and opioid receptors in human brain tumors
1990 • 59 citations
Interactions of 16α-[18F]-fluoroestradiol (FES) with sex steroid binding protein (SBP)
1999 • 57 citations
in vivo evaluation of [18F]1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine: A Selective sigma-1 receptor radioligand for PET
1997 • 57 citations
Sigma receptors are expressed in human non-small cell lung carcinoma
1995 • 57 citations
Enhancement of acetylcholine release by SA4503, a novel sigma 1 receptor agonist, in the rat brain.
1996 • 56 citations
Phencyclidine Impairs Latent Learning in Mice Interaction between Glutamatergic Systems and Sigma1 Receptors
2001 • 55 citations
[3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.
1993 • 55 citations
Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine.
1988 • 55 citations
Activation of σ1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures
1998 • 54 citations
Effects of σ1 receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats
2000 • 54 citations
DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'-oxoethyl)- piperidine HBr], a sigma and 5-hydroxytryptamine2 receptor antagonist: receptor-binding, electrophysiological and neuropharmacological profiles.
1992 • 53 citations
Potential antidepressant activity of sigma ligands.
2004 • 53 citations
Antidepressant Treatment of Psychotic Major Depression: Potential Role of the σ Receptor
2005 • 53 citations
Differential involvement of the sigma1 (σ1) receptor in the anti‐amnesic effect of neuroactive steroids, as demonstrated using an in vivo antisense strategy in the mouse
2001 • 51 citations
Modulation of steroidal levels by adrenalectomy/castration and inhibition of neurosteroid synthesis enzymes affect σ1 receptor‐mediated behaviour in mice
1999 • 51 citations
Prostate cancer and prostate bed SPECT imaging with ProstaScint®: Semiquantitative correlation with prostatic biopsy results
1998 • 51 citations
Preclinical evaluation of [11C]SA4503: radiation dosimetry,in vivo selectivity and PET imaging of sigma1 receptors in the cat brain
2000 • 50 citations
Halogenated 4-(Phenoxymethyl)piperidines as Potential Radiolabeled Probes for σ-1 Receptors: In Vivo Evaluation of [123I]-1-(Iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]piperidine
1997 • 50 citations
Cocaine-sensitive sigma-receptor and its interaction with steroid hormones in the human placental syncytiotrophoblast and in choriocarcinoma cells.
1995 • 49 citations
Immunopharmacological profile of SR 31747: In vitro and in vivo studies on humoral and cellular responses
1994 • 49 citations
True
2000 • 48 citations
Autoradiographic distribution of sigma receptors in human neocortex, hippocampus, basal ganglia, cerebellum, pineal and pituitary glands
1991 • 48 citations
σ1 Receptors in rat striatum regulate NMDA-stimulated [3H]dopamine release via a presynaptic mechanism
1995 • 47 citations
Sigma 1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain.
1997 • 47 citations
Synthesis and evaluation of [18F] labeled benzamides: High affinity sigma receptor ligands for PET imaging
1997 • 47 citations
Effect of SA4503, a novel σ1 receptor agonist, against glutamate neurotoxicity in cultured rat retinal neurons
1998 • 47 citations
Conformational Analysis, Pharmacophore Identification, and Comparative Molecular Field Analysis of Ligands for the Neuromodulatory .sigma.3 Receptor
1994 • 46 citations
Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency
2004 • 46 citations
Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523
2001 • 45 citations
Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry.
1993 • 44 citations
Bcl-2–related antisense therapy
2002 • 41 citations
Regional distribution and kinetics of haloperidol binding in human brain: A pet study with [18F]haloperidol
1992 • 41 citations
A placebo‐controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation
1990 • 40 citations
PET and SPECT Exploration of Central Monoaminergic Transporters for the Development of New Drugs and Treatments in Brain Disorders
2005 • 40 citations
Expression of bcl-2 by breast cancer: a possible diagnostic application.
1996 • 39 citations
Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study
1999 • 39 citations
NE-100, a novel sigma receptor ligand: Effect on phencyclidine-induced behaviors in rats, dogs and monkeys
1994 • 39 citations
σ Receptor ligands (+)-SKF10,047 and SA4503 improve dizocilpine-induced spatial memory deficits in rats
1998 • 39 citations
Open clinical trial on the sigma ligand panamesine in patients with schizophrenia
1997 • 38 citations
PET Imaging in Clinical Drug Abuse Research
2005 • 38 citations
Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1′-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer
1999 • 38 citations
Synthesis, structure and quantitative structure-activity relationships of σ receptor ligands, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines
1997 • 37 citations
Enhanced antidepressant efficacy of σ1 receptor agonists in rats after chronic intracerebroventricular infusion of β-amyloid-(1–40) protein
2004 • 37 citations
Review of the Pharmacological and Clinical Profile of Rimcazole
2004 • 37 citations
Synthesis, In Vitro Binding, and Tissue Distribution of Radioiodinated 2-[125I]N-(N-Benzylpiperidin-4-yl)-2-Iodo Benzamide, 2-[125I]BP: A Potential σ Receptor Marker for Human Prostate Tumors
1998 • 37 citations
The value of positron emission tomography (PET) imaging in disease staging and therapy assessment
2002 • 35 citations
Lu 28-179 labels a σ2-site in rat and human brain
2002 • 35 citations
Radiosynthesis of .sigma. receptor ligands for positron emission tomography: carbon-11 and fluorine-18 labeled guanidines
1991 • 35 citations
Evidence that the σ1 receptor is not directly coupled to G proteins
2000 • 35 citations
Clinical Applications of FDG‐PET in Oncology
2002 • 35 citations
In vitro progesterone effects on 3H-dopamine release from rat corpus striatum slices obtained under different endocrine conditions
1993 • 34 citations
Efficacy and Safety of an Opiate Sigma-Receptor Antagonist (SL 82.0715) in Schizophrenic Patients with Negative Symptoms: an Open Dose-Range Study
1996 • 34 citations
N-(N-Benzylpiperidin-4-yl)-2-[18F]fluorobenzamide: A potential ligand for PET imaging of σ receptors
1997 • 34 citations
Trishomocubanes: novel σ-receptor ligands modulate amphetamine-stimulated [3H]dopamine release
2001 • 34 citations
Enhanced antidepressant effect of sigma1 (σ1) receptor agonists in β25–35-amyloid peptide-treated mice
2002 • 33 citations
The involvement of dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) in blocking the therapeutic effect of electroconvulsive shocks in an animal model of depression
2005 • 33 citations
Effect of NE-100, a novel σ receptor ligand, on phencyclidine-induced cognitive dysfunction
1994 • 33 citations
Molecular modeling of σ1 receptor ligands: a model of binding conformational and electrostatic considerations
2003 • 33 citations
Synthesis and evaluation of [18F]fluoroethyl SA4503 as a PET ligand for the sigma receptor
2002 • 33 citations
[18F]N-4′-Fluorobenzyl-4-(3-bromophenyl) acetamide for imaging the sigma receptor status of tumors: comparison with [18F]FDG and [125I]IUDR
2001 • 32 citations
Synthesis and Quantitative Structure−Activity Relationships of N-(1-Benzylpiperidin-4-yl)phenylacetamides and Related Analogues as Potent and Selective σ1 Receptor Ligands
1998 • 32 citations
Efficacy and Safety of the Sigma Receptor Ligand EMD 57445 (Panamesine) in Patients with Schizophrenia: an Open Clinical Trial
1999 • 31 citations
Behavioral Pharmacology of σ-Ligands
2004 • 31 citations
Examination of four 123I-labeled piperidine-based sigma receptor ligands as potential melanoma imaging agents: Initial studies in mouse tumor models
1997 • 31 citations
99mTc-Labeled σ-Receptor-Binding Complex: Synthesis, Characterization, and Specific Binding to Human Ductal Breast Carcinoma (T47D) Cells
1997 • 31 citations
Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical results.
2002 • 30 citations
Synthesis and PET studies of fluorine-18-BMY 14802: a potential antipsychotic drug.
1993 • 30 citations
Evaluation of prostate cancer patients receiving multiple staging tests, including ProstaScint� scintiscans
2000 • 29 citations
Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer.
1997 • 29 citations
Sigma Receptor Antagonists Inhibit Human Lens Cell Growth and Induce Pigmentation
2005 • 29 citations
Ameliorative Effect of SA4503, a Novel Cognitive Enhancer, on the Basal Forebrain Lesion-Induced Impairment of the Spatial Learning Performance in Rats
1998 • 29 citations
A double‐blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia
1990 • 29 citations
Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-Iodophenyl)Ethyl]-N-Methyl-2-(1-Piperidinyl) ethylamine: A high-affinity ligand for imaging sigma receptor positive tumors
1996 • 28 citations
Apparent desensitization of a σ receptor sub-population in neonatal rat cardiac myocytes by pre-treatment with σ receptor ligands
1996 • 28 citations
The influences of blood glucose and duration of fasting on myocardial glucose uptake of [18F]fluoro-2-deoxy-D-glucose
2002 • 28 citations
Breast cancer staging using technetium-99m sestamibi and indium-111 pentetreotide single-photon emission tomography
1997 • 28 citations
Effect of SA4503 on the electrically evoked release of3H-acetylcholine from striatal and hippocampal rat brain slices
2002 • 28 citations
Substituted Halogenated Arylsulfonamides: A New Class of σ Receptor Binding Tumor Imaging Agents
1998 • 26 citations
Synthesis and preliminary evaluation of [123I]1-(4-cyanobenzyl)-4-[[(trans-iodopropen-2-yl)oxy]-methyl]piperidine: A novel high affinity sigma receptor radioligand for SPECT
1997 • 26 citations
Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor
1999 • 26 citations
Does sigma receptor antagonism predict clinical antipsychotic efficacy?
1991 • 25 citations
Preclinical acute toxicity studies and rodent-based dosimetry estimates of the novel sigma-1 receptor radiotracer [18F]FPS
2003 • 25 citations
Remoxipride and haloperidol in schizophrenia: a double‐blind multicentre study.
1990 • 24 citations
Sigma ligands stimulate GTPase activity in mouse prefrontal membranes: evidence for the existence of metabotropic sigma receptor
1997 • 24 citations
DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'- oxoethyl)piperidine HBr], a potential antipsychotic agent: preclinical behavioral effects.
1992 • 23 citations
Attenuation of Scopolamine-Induced and Age-Associated Memory Impairments by the Sigma and 5-Hydroxytryptamine1A Receptor Agonist OPC-14523 (1-{3-[4-(3-chlorophenyl)-1-piperazinyl]propyl}-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate)
2002 • 23 citations
Progesterone in vitro increases NMDA-evoked [3H]dopamine release from striatal slices in proestrus rats
1996 • 23 citations
Synthesis and in vivo evaluation of [11C]SA6298 as a PET sigma1 receptor ligand
1999 • 23 citations
Nuclear Medicine Techniques for the Diagnosis and Therapy of Prostate Carcinoma
2001 • 23 citations
The selective σ1 receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (−)-nicotine in rats
2001 • 22 citations
New Molecular Targets of Breast Cancer Therapy
2002 • 22 citations
Clinical oncologic positron emission tomography: An introduction
2002 • 22 citations
Steroid Binding at σ Receptors: CNS and Immunological Implications
2007 • 22 citations
Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients
1990 • 22 citations
Autoradiographic identification and characterization of σ receptors in guinea pig brain using [3H]1(cyclopropylmethyl)-4-(2′-(4≈-fluorophenyl)-2′-oxoethyl) piperidine ([3H]DuP 734), a novel σ receptor ligand
1992 • 21 citations
Ligands for opioid and σ-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress
1999 • 21 citations
Synthesis of (±)-[18F]BMY 14802, its enantiomers and their anatomical distributions in rodents
1993 • 19 citations
N-(n-benzylpiperidin-4-yl)-2-[18f]fluorobenzamide: a potential ligand for pet imaging of breast cancer
2000 • 19 citations
Increased binding to sigma sites of N-[1′(2-piperidinyl)ethyl)-4-[I-125]-iodobenzamide (I-125-PAB) with onset of tumor cell proliferation
1998 • 19 citations
[3H]YM-09151–2 (nemonapride), a potent radioligand for both sigma1 and sigma2 receptor subtypes
1996 • 19 citations
Reduction of IL-10 and Nitric Oxide Synthesis by SR31747A (Sigma Ligand) in RAW Murine Macrophages
2001 • 18 citations
Untitled
2001 • 18 citations
[Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
1998 • 18 citations
Sigma and Phencyclidine Receptors in the Brain-Endocrine-Immune Axis
1993 • 18 citations
Novel Sigma Binding Site Ligands as Inhibitors of Cell Proliferation in Breast Cancer
2003 • 18 citations
Putative σ3 sites in mammalian brain have histamine H1 receptor properties: evidence from ligand binding and distribution studies with the novel H1 radioligand [ ]-(−)-trans-1-phenyl-3-aminotetralin
1999 • 17 citations
Uptake of 99mTc-MIBI and 99mTc-tetrofosmin into malignant versus nonmalignant breast cell lines.
2000 • 16 citations
Dueling Enigmas: Neurosteroids and Sigma Receptors in the Limelight
2000 • 16 citations
Imaging prostate derived tumors with PET and N-(3-[18F]fluoropropyl)putrescine
1990 • 15 citations
In Vitro and In Vivo Expression of Opioid and σ Receptors in Rat C6 Glioma and Mouse N18TG2 Neuroblastoma Cells
1994 • 14 citations
Synthesis and receptor binding properties of fluoro- and iodo-substituted high-affinity .sigma.-receptor ligands: identification of potential PET and SPECT .sigma.-receptor imaging agents
1992 • 14 citations
Clinical oncological applications of Positron Emission Tomography (PET) using fluorine-18-fluoro-2-deoxy-D-glucose.
2002 • 14 citations
Microdialysis and 2-[18F]fluoro-2-deoxy-D-glucose (FDG): A study on insulin action on FDG transport, uptake and metabolism in rat muscle, liver and adipose tissue
2003 • 14 citations
Possible Involvement of a σ Receptor Subtype in the Neck Dystonia in Rats
1999 • 14 citations
Synthesis of a selective sigma receptor radioligand for SPECT: [123I]-1-(2-hydroxyethyl)-4-(4-iodophenoxymethyl)piperidine
1996 • 14 citations
A comparative molecular field analysis (CoMFA) study using semiempirical, density functional, ab initio methods and pharmacophore derivation using DISCOtech on sigma 1 ligands
2004 • 14 citations
Turnover rate and stimulus-evoked release of dopamine by progesterone and N-methyl-d-aspartic acid in rat striatum during pregnancy
1996 • 13 citations
The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging
2002 • 12 citations
The value of early and double phase 99Tcm-sestamibi scintimammography in the diagnosis of breast cancer
2000 • 12 citations
[18F]Haloperidol binding in baboon brain in vivo
1996 • 12 citations
A shifting landseape: What will be next FDG in PET oncology?
2002 • 11 citations
Breast cancer imaging: The future
2001 • 10 citations
Investigation of the Use of Positron Emission Tomography for Neuroreceptor Imaging in Rabbit Eyes
2004 • 9 citations
Characterization of the sigma ligand panamesine, a potential antipsychotic, by immune response in patients with schizophrenia and by sleep-EEG changes in normal controls
1999 • 9 citations
Focus on Molecules: the Sigma-1 Receptor
2005 • 9 citations
Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
1997 • 9 citations
Analysis of FDG uptake with hybrid PET using standardised uptake values
2001 • 7 citations
Positron emission tomography study of human prostatic adenocarcinoma using carbon-11 putrescine
1994 • 7 citations
Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol.
1990 • 7 citations
La TEP au 〚18F〛-fluoro-2-désoxyglucose dans l’imagerie des cancers gynécologiques
2001 • 6 citations
Delayed Tc-99m Citrate Scintigraphy in the Evaluation of Palpable Breast Masses
1999 • 6 citations
Identification and pharmacological characterization of SRBP-2: a novel SR31747A-binding protein.
2003 • 6 citations
Variability of insulin-stimulated myocardial glucose uptake in healthy elderly subjects
2002 • 5 citations
[Are sigma receptors implicated in ischemic injury?].
2002 • 5 citations
Current Strategies for the Development of Novel Antipsychotic Drugs
2003 • 5 citations
[Opioid system and cardiac resistance to ischemic and reperfusion injuries].
2000 • 4 citations
[Dependence of the pump function of the isolated rat heart on the functional activity of sigma receptors during reperfusion].
1999 • 3 citations
Pharmacological Effects of .SIGMA.-Receptor Ligands. Anti-amnesic effects of sigma (.SIGMA.)-receptor agonists.
1999 • 3 citations
[Uptake of FDG (2-fluoro-2-deoxy-D-glucose) as a tumor imaging agent into erythrocytes and accumulation of FDG in tumor cells].
2003 • 3 citations
Sigma1 Receptor Subtype Does Not Interact With Stereotyped Behaviors in Rats
1998 • 3 citations
[Ligands of opioid and sigma receptors and correction of cardiac electrical instability in post-infarction cardiosclerosis].
2001 • 2 citations
Combined treatment with NMDA antagonist, CGP 37849, and sigma receptor agonists, SA4503 or DTG, decreases the neuroleptic-induced catalepsy in rats.
2001 • 1 citations